Bespak Reaches Milestone in Capacity Expansion for Greener Inhalers

Further expansion plans underway to meet global customer demand for climate friendly inhalers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bespak, a contract development and manufacturing organization (CDMO) focused on orally inhaled and nasal drug-device combination products, unveiled progress in its commitment to the production of low global warming potential (GWP) pressurized metered dose inhalers (pMDIs) with the arrival of its new high-speed commercial filling equipment on site, and commitment to further capacity expansion with an additional high-speed commercial filling line planned. These expansions will enable Bespak to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters